'1038 nrclinonc' diaporamas de présentation

Figure 1 Proposed mechanisms for metastasis suppression by PEBP1, RECK, and CTGF in colon cancer

Figure 1 Proposed mechanisms for metastasis suppression by PEBP1, RECK, and CTGF in colon cancer. Shoushtari, A. N. et al. (2011) Metastasis-suppressor genes in clinical practice: lost in translation? Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2011.65.

115 views • 1 slides

Figure 1 The effects of radiotherapy as postsurgical treatment of glioblastoma

Figure 1 The effects of radiotherapy as postsurgical treatment of glioblastoma. Yang, I. and Aghi, M. K. (2009) New advances that enable identification of glioblastoma recurrence Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2009.150.

149 views • 1 slides

Figure 4 Conventional T1 gadolinium?enhanced MRI appearance of radiation necrosis

Figure 4 Conventional T1 gadolinium?enhanced MRI appearance of radiation necrosis. Yang, I. and Aghi, M. K. (2009) New advances that enable identification of glioblastoma recurrence Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2009.150.

153 views • 1 slides

Figure 1 Clinical results of combinations of PFS and overall survival

124 views • 1 slides

Table 3 VEGF pathway?targeted drugs currently in neoadjuvant clinical trials

154 views • 1 slides

139 views • 1 slides

Table 1 Patient selection guidelines from selected groups for APBI

Table 1 Patient selection guidelines from selected groups for APBI. Cox, J. A. & Swanson, T. A. ( 2013) Current modalities of accelerated partial breast irradiation Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2013.65.

89 views • 1 slides

Table 1 Phase III trials with a survival benefit in metastatic CRPC

Table 1 Phase III trials with a survival benefit in metastatic CRPC. Sartor, O. & Pal, S. K. ( 2012) Abiraterone and its place in the treatment of metastatic CRPC Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.202.

120 views • 1 slides

Table 4 Assessing the impact of dMMR on response to irinotecan

Table 4 Assessing the impact of dMMR on response to irinotecan. Hewish, M. et al . (2010) Mismatch repair deficient colorectal cancer in the era of personalized treatment Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.18.

117 views • 1 slides

Figure 3 The impact of dMMR on the management of colorectal cancer

Figure 3 The impact of dMMR on the management of colorectal cancer. Hewish, M. et al . (2010) Mismatch repair deficient colorectal cancer in the era of personalized treatment Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.18.

168 views • 1 slides

Table 3 Trials assessing the effect of dMMR on 5-FU-based treatment outcomes

Table 3 Trials assessing the effect of dMMR on 5-FU-based treatment outcomes. Hewish, M. et al . (2010) Mismatch repair deficient colorectal cancer in the era of personalized treatment Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.18.

144 views • 1 slides

Table 1 Immunological approaches for detection of DTCs/CTCs

Table 1 Immunological approaches for detection of DTCs/CTCs. Pantel K et al . (2009) Cancer micrometastases Nat Rev Clin Oncol doi:10.1038/nrclinonc.2009.44.

117 views • 1 slides

Figure 3 Global Cumulative Treatment Analysis (GCTA)

Figure 3 Global Cumulative Treatment Analysis (GCTA). Shrager, J. & Tenenbaum, J. M. ( 2014) Rapid learning for precision oncology Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2013.244.

162 views • 1 slides

Borchmann, P. et al. ( 2012) State of the art in the treatment of Hodgkin lymphoma

Figure 4 Study designs of the GITIL HD0607 trial and the GHSG HD18 (NCT00515554) trial for patients with newly diagnosed advanced-stage HL. Borchmann, P. et al. ( 2012) State of the art in the treatment of Hodgkin lymphoma Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.91.

309 views • 1 slides

Table 1 Planned or ongoing clinical trials of radioembolization in patients with mCRC

Table 1 Planned or ongoing clinical trials of radioembolization in patients with mCRC. Nicolay, N. H. et al. (2009) Liver metastases from colorectal cancer: radioembolization with systemic therapy Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2009.165.

144 views • 1 slides

Figure 3 Heterogeneity of CTCs based on expression of epithelial and mesenchymal antigens

113 views • 1 slides

Figure 6 MRSI showing regional metabolite variation in a heterogeneous tumour

Figure 6 MRSI showing regional metabolite variation in a heterogeneous tumour. Peet, A. C. et al. ( 2012) Functional imaging in adult and paediatric brain tumours Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.187.

119 views • 1 slides

nrclinonc.2012.61-pf2

95 views • 1 slides

Figure 3 Predictive biomarker development strategy in PDTX models

166 views • 1 slides

Jones, C. et al. ( 2012) Paediatric and adult malignant glioma: close relatives or

Figure 1 Objective response rates of single-agent chemotherapy trials (of carboplatin, cisplatin, nitrosourea, etoposide, ifosfamide, irinotecan and temozolomide) in adult and paediatric (including DIPG) HGG. Jones, C. et al. ( 2012) Paediatric and adult malignant glioma: close relatives or

170 views • 1 slides